Loading activity…
@bobjherman
Health care business reporter for @statnews and author of the Health Care Inc. newsletter. Contact: bob.herman@statnews.com or bobjherman.09 on Signal.
Science
STAT reports a shift from promoting GLP-1 drugs as tools to address obesity as a medical issue toward a lifestyle pitch.